tradingkey.logo

Movano Inc

MOVE

0.630USD

-0.001-0.22%
Close 08/04, 16:00ETQuotes delayed by 15 min
4.31MMarket Cap
LossP/E TTM

Movano Inc

0.630

-0.001-0.22%
More Details of Movano Inc Company
Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
Company Info
Ticker SymbolMOVE
Company nameMovano Inc
IPO dateMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
Number of employees32
Security typeOrdinary Share
Fiscal year-endMar 23
Address6800 Koll Center Parkway
CityPLEASANTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94566
Phone14083931209
Websitehttps://movanohealth.com/
Ticker SymbolMOVE
IPO dateMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
246.22K
+153.93%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
216.16K
+183.54%
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
118.36K
+33.73%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
67.61K
+38.11%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Director
Director
47.73K
+64.18%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jill Schmidt
Ms. Jill Schmidt
IR Contact Officer
IR Contact Officer
--
--
Ms. Emily Wang Fairbairn
Ms. Emily Wang Fairbairn
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
246.22K
+153.93%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
216.16K
+183.54%
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
118.36K
+33.73%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
67.61K
+38.11%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Director
Director
47.73K
+64.18%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 9
Updated: Wed, Jul 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Appel (Peter A)
9.22%
Fairbairn Emily Wang
6.93%
Mairs and Power, Inc.
5.33%
Fairbairn (Malcolm P.)
5.22%
Robert W. Baird & Co. Inc.
4.60%
Other
68.69%
Shareholders
Shareholders
Proportion
Appel (Peter A)
9.22%
Fairbairn Emily Wang
6.93%
Mairs and Power, Inc.
5.33%
Fairbairn (Malcolm P.)
5.22%
Robert W. Baird & Co. Inc.
4.60%
Other
68.69%
Shareholder Types
Shareholders
Proportion
Individual Investor
34.64%
Investment Advisor
9.34%
Investment Advisor/Hedge Fund
6.94%
Hedge Fund
2.32%
Research Firm
0.05%
Other
46.71%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
56
3.24M
46.10%
+457.22K
2025Q1
56
2.83M
40.61%
+410.10K
2024Q4
56
2.31M
34.88%
+869.72K
2024Q3
55
2.03M
30.72%
+612.32K
2024Q2
55
2.06M
31.25%
+706.69K
2024Q1
50
720.48K
20.03%
+1.88K
2023Q4
47
725.57K
20.17%
+32.23K
2023Q3
46
940.36K
29.66%
+64.17K
2023Q2
45
886.33K
28.12%
+52.17K
2023Q1
44
830.67K
33.29%
+248.86K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Appel (Peter A)
648.80K
9.22%
+657.00
+0.10%
Mar 21, 2025
Fairbairn Emily Wang
459.88K
6.54%
+65.41K
+16.58%
May 09, 2025
Mairs and Power, Inc.
375.34K
5.33%
--
--
Mar 31, 2025
Fairbairn (Malcolm P.)
367.57K
5.22%
+2.00
+0.00%
Mar 21, 2025
Robert W. Baird & Co. Inc.
323.94K
4.6%
+11.37K
+3.64%
Mar 31, 2025
Mastrototaro (John)
96.96K
1.38%
+77.52K
+398.71%
May 09, 2025
Cogan (Jeremy D.)
115.03K
1.63%
+62.99K
+121.03%
May 09, 2025
Leabman (Michael Aaron)
76.24K
1.08%
+72.67K
+2039.11%
May 09, 2025
The Vanguard Group, Inc.
213.70K
3.04%
+95.45K
+80.72%
Mar 31, 2025
Clayton Partners LLC
143.48K
2.04%
+30.71K
+27.23%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
Date
Type
Ratio
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
Oct 25, 2024
Merger
15<1
KeyAI